PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()

The potential of PACE4 as a pharmacological target in prostate cancer has been demonstrated as this proprotein convertase is strongly overexpressed in human prostate cancer tissues and its inhibition, using molecular or pharmacological approaches, results in reduced cell proliferation and tumor prog...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neoplasia
Glavni autori: Couture, Frédéric, Levesque, Christine, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, D’Anjou, François, Day, Robert, Guérin, Brigitte
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4235008/
https://ncbi.nlm.nih.gov/pubmed/25220591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.07.010
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items